Syed Gulam Hussain, Tang Huihui, Khan Mohsin, Hassanein Tarek, Liu Jingwen, Siddiqui Aleem
Department of Medicine, Division of Infectious Diseases, University of California, San Diego, La Jolla, California, USA.
J Virol. 2014 Mar;88(5):2519-29. doi: 10.1128/JVI.02727-13. Epub 2013 Dec 18.
Lipids play a crucial role in multiple aspects of hepatitis C virus (HCV) life cycle. HCV modulates host lipid metabolism to enrich the intracellular milieu with lipids to facilitate its proliferation. However, very little is known about the influence of HCV on lipid uptake from bloodstream. Low-density lipoprotein receptor (LDLR) is involved in uptake of cholesterol rich low-density lipoprotein (LDL) particles from the bloodstream. The association of HCV particles with lipoproteins implicates their role in HCV entry; however, the precise role of LDLR in HCV entry still remains controversial. Here, we investigate the effect of HCV infection on LDLR expression and the underlying mechanism(s) involved. We demonstrate that HCV stimulates LDLR expression in both HCV-infected Huh7 cells and in liver tissue from chronic hepatitis C patients. Fluorescence activated cell sorting and immunofluorescence analysis revealed enhanced cell surface and total expression of LDLR in HCV-infected cells. Increased LDLR expression resulted in the enhanced uptake of lipoprotein particles by HCV-infected cells. Analysis of LDLR gene promoter identified a pivotal role of sterol-regulatory element binding proteins (SREBPs), in the HCV-mediated stimulation of LDLR transcription. In addition, HCV negatively modulated the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that facilitates LDLR degradation. Ectopic expression of wild-type PCSK9 or gain-of-function PCSK9 mutant negatively affected HCV replication. Overall, our results demonstrate that HCV regulates LDLR expression at transcriptional and posttranslational level via SREBPs and PCSK9 to promote lipid uptake and facilitate viral proliferation.
HCV modulates host lipid metabolism to promote enrichment of lipids in intracellular environment, which are essential in multiple aspects of HCV life cycle. However, very little is known about the influence of HCV on lipid uptake from the bloodstream. LDLR is involved in uptake of cholesterol rich lipid particles from bloodstream. In this study, we investigated the effect of HCV on LDLR expression and the underlying mechanism triggered by the virus to modulate LDLR expression. Our observations suggest that HCV upregulates LDLR expression at both the protein and the transcript levels and that this upregulation likely contributes toward the uptake of serum lipids by infected hepatocytes. Abrogation of HCV-mediated upregulation of LDLR inhibits serum lipid uptake and thereby perturbs HCV replication. Overall, our findings highlight the importance of serum lipid uptake by infected hepatocytes in HCV life cycle.
脂质在丙型肝炎病毒(HCV)生命周期的多个方面发挥着关键作用。HCV调节宿主脂质代谢,使细胞内环境富含脂质以促进其增殖。然而,关于HCV对血液中脂质摄取的影响知之甚少。低密度脂蛋白受体(LDLR)参与从血液中摄取富含胆固醇的低密度脂蛋白(LDL)颗粒。HCV颗粒与脂蛋白的关联暗示了它们在HCV进入中的作用;然而,LDLR在HCV进入中的确切作用仍存在争议。在此,我们研究了HCV感染对LDLR表达的影响及其潜在机制。我们证明,HCV在HCV感染的Huh7细胞和慢性丙型肝炎患者的肝组织中均刺激LDLR表达。荧光激活细胞分选和免疫荧光分析显示,HCV感染细胞中LDLR的细胞表面表达和总表达均增强。LDLR表达增加导致HCV感染细胞对脂蛋白颗粒的摄取增强。对LDLR基因启动子的分析确定了固醇调节元件结合蛋白(SREBPs)在HCV介导的LDLR转录刺激中的关键作用。此外,HCV负向调节前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)的表达,PCSK9是一种促进LDLR降解的蛋白质。野生型PCSK9或功能获得性PCSK9突变体的异位表达对HCV复制产生负面影响。总体而言,我们的结果表明,HCV通过SREBPs和PCSK9在转录和翻译后水平调节LDLR表达,以促进脂质摄取并促进病毒增殖。
HCV调节宿主脂质代谢以促进细胞内环境中脂质的富集,这在HCV生命周期的多个方面至关重要。然而,关于HCV对血液中脂质摄取的影响知之甚少。LDLR参与从血液中摄取富含胆固醇的脂质颗粒。在本研究中,我们研究了HCV对LDLR表达的影响以及病毒触发调节LDLR表达的潜在机制。我们的观察结果表明,HCV在蛋白质和转录水平上均上调LDLR表达,并且这种上调可能有助于受感染的肝细胞摄取血清脂质。消除HCV介导的LDLR上调会抑制血清脂质摄取,从而干扰HCV复制。总体而言,我们的研究结果突出了受感染的肝细胞摄取血清脂质在HCV生命周期中的重要性。